Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment

Mesenchymal stem cells (MSCs) are promising cells to treat cartilage defects due to their chondrogenic differentiation potential. However, an inflammatory environment during differentiation, such as the presence of the cytokine TNFα, inhibits chondrogenesis and limits the clinical use of MSCs. On th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Bioeng Biotechnol
Päätekijät: Voskamp, Chantal, Koevoet, Wendy J. L. M., Somoza, Rodrigo A., Caplan, Arnold I., Lefebvre, Véronique, van Osch, Gerjo J. V. M., Narcisi, Roberto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Bioengineering and Biotechnology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344141/
https://ncbi.nlm.nih.gov/pubmed/32714905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00658
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia